Wutah dodolan YoY sajrone rolas wulan kepungkur: Agape ATP Corporation (ATPC)

Logo grafis agapeatpgroup.com (ATPC)

Agape ATP Corporation (ATPC) is facing regulatory challenges and insufficient reporting transparency within its Asian structure. Intense competition from the wellness sector and low barriers to entry create additional risks. The year-over-year sales trajectory over the trailing four quarters demonstrates revenue dynamics, where -26.50 characterizes this valuation parameter. Meanwhile, the brand maintains strong loyalty among wellness program consumers in the Eastern region.

Wutah dodolan YoY sajrone rolas wulan kepungkur: agapeatpgroup.com (ATPC) kanggo 23.11.2025 - 18.11.2026

Agape ATP Corp (ATPC) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:ATPC, agapeatpgroup.com
Produk seri Agape ATP

Investors are seeking confirmation of business model scalability within the Agape ATP Corporation (ATPC) financial reports. This metric measures the percentage shift in revenue over a rolling year, neutralizing seasonal distortions. By analyzing the Last Twelve Months (LTM) growth rate of commercial revenue, one can assess the effectiveness of acquiring new users via digital services. This price action reflects the viability of the wellness ecosystem and the loyalty of the elderly demographic. Steady growth here confirms the resilience of the company's fundamental base.

Karo sapa Agape ATP Corporation saingan

Ascendis (ASND) - Wutah pendapatan taun lumaku|MDGL - Wutah dodolan YoY sajrone rolas wulan kepungkur|CORT: Wutah dodolan YoY sajrone rolas wulan kepungkur|RYTM: Wutah dodolan YoY (TTM)|AKRO - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Metsera Therapeutics|MoonLake Corp (MLTX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur crinetics.com (CRNX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur newamsterdampharma.com NAMS|Wutah dodolan YoY sajrone rolas wulan kepungkur Soleno Therapeutics Inc SLNO|Wutah dodolan YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Wutah dodolan YoY (TTM)|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur MiMedx Group, Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) MBX|Wutah pendapatan YoY sajrone 12 wulan kepungkur Altimmune, Inc. ALT|Wutah dodolan YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Wutah pendapatan taun lumaku|BIOA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur BMEA (Biomea Fusion)|QNCX (quincetx.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Fractyl - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|VTVT (vTv Therapeutics Inc) - Wutah dodolan YoY (TTM)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Pluri (PLUR)|Wutah dodolan YoY (TTM) SYBX|Wutah pendapatan taunan sajrone rolas wulan kepungkur Lipocine Inc|Wutah dodolan YoY sajrone rolas wulan kepungkur Matinas BioPharma Holdings MTNB|Wutah pendapatan taunan sajrone rolas wulan kepungkur Spruce Biosciences (SPRB)|GLTO: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku CTCX|LUMO (Lumos Pharma) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone 12 wulan kepungkur ONVO|RDUS (Radius Pharmaceuticals) - Wutah dodolan YoY (TTM)